Paper Details

  1. Home
  2. Paper Details

Treatment of erythrodermic psoriasis with biologics: A systematic review.

Author: Arias-BerriosGabriel, Cancel-ArtauKarina J, CarrasquilloOsward Y, Falto-AizpuruaLeyre A, Martín-GarcíaRafael F, Pabón-CartagenaGabriela, Santiago-VázquezMarely

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This review analyzed the evidence of biologic medications in the treatment of erythrodermic psoriasis (EP). It found that most patients with EP treated with biologics demonstrated positive responses and treatment was well-tolerated. There was a higher level of evidence in favor of infliximab, ustekinumab, ixekizumab, and guselkumab.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Biologic medications for plaque psoriasis have been used to treat erythrodermic psoriasis (EP). Since the guidelines for management of EP were published, new biologic medications have been approved for the treatment of plaque psoriasis. OBJECTIVE: To analyze the evidence of biologic med...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jaad.2020.03.073

データ提供：米国国立医学図書館（NLM）

Biologic Medications for Erythrodermic Psoriasis: A Comprehensive Review

This study explores the use of biologic medications in treating erythrodermic psoriasis, a severe form of psoriasis that affects a large portion of the body's surface. It's like venturing into a specialized area within dermatology, seeking effective treatments for a challenging skin condition.

The researchers conducted a systematic review of studies examining the effectiveness of biologic medications in treating erythrodermic psoriasis, analyzing data from case reports, case series, and uncontrolled studies. They found that biologic medications, like infliximab, ustekinumab, ixekizumab, and guselkumab, showed promising results in treating erythrodermic psoriasis, suggesting a potential role for these medications in managing this severe skin condition.

The Potential of Biologic Medications for Erythrodermic Psoriasis

This study offers hope for patients with erythrodermic psoriasis, highlighting the potential of biologic medications as an effective treatment option. It's like discovering a new weapon in the fight against this debilitating skin condition, offering relief and improving quality of life.

Implications for Psoriasis Treatment and Future Research

This research underscores the need for further research on the use of biologic medications for erythrodermic psoriasis, emphasizing the importance of rigorous clinical trials to confirm their effectiveness and safety. It's like recognizing that a new frontier has been opened, but more exploration is needed to fully understand its potential. This research can lead to improved treatment guidelines and personalized therapies for patients with erythrodermic psoriasis.

Dr. Camel's Conclusion

Navigating the complexities of psoriasis treatment is like journeying through a vast desert, searching for effective solutions. This study, like a refreshing oasis, highlights the potential of biologic medications for erythrodermic psoriasis, offering hope for patients and providing a new direction for dermatological research. It's a reminder that the journey of discovery is ongoing, and the quest for better treatments continues.

Date :
  1. Date Completed 2021-01-21
  2. Date Revised 2021-01-21
Further Info :

Pubmed ID

32247872

DOI: Digital Object Identifier

10.1016/j.jaad.2020.03.073

Related Literature

Article Analysis
・Effective treatment of psoriasis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.